Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Avastin Launch Unlikely To Affect Xeloda Sales, Roche Says

Apr 26 2004

• By The Pink Sheet

Related Content

Genentech Avastin Clears FDA; Colorectal Cancer Drug Costs $4,400 A Month

Mar 01 2004

Genentech Avastin Early Sales Data Suggest Broad Use In Colorectal Cancer

Apr 12 2004

Roche Re-Opens Bank Account: Firm Again A Creditor After Genentech Sale

Apr 03 2000

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window